Innocan 50 is a capsule containing Fluconazole BP 50 mg. It is manufactured by Radiant Pharmaceuticals Ltd. in Bangladesh. 

Indications:

Innocan 50 (Fluconazole) is an antifungal medication belonging to the triazole class. It is used to treat a wide range of fungal infections, including: 

• Vaginal candidiasis (acute or recurrent yeast infections). 
• Mucosal candidiasis (e.g., oropharyngeal candidiasis (thrush), esophageal candidiasis, candiduria (fungal infection in urine), mucocutaneous candidiasis). 
• Systemic candidiasis (e.g., candidemia, disseminated candidiasis, and other forms of invasive candidal infections of the peritoneum, endocardium, pulmonary, and urinary tracts). 
• Cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g., pulmonary, cutaneous). It can also be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with AIDS. 
• Dermal fungal infections like Tinea pedis (athlete's foot), Tinea cruris (jock itch), Tinea corporis (ringworm), Tinea versicolor, and onychomycosis (nail fungal infections). 
• Prophylaxis of fungal infections in immunocompromised patients, particularly those undergoing bone marrow transplantation or neutropenia following cytotoxic chemotherapy or radiotherapy. 
• Other systemic fungal infections such as coccidioidomycosis and histoplasmosis. 

Pharmacology:

Fluconazole works by selectively inhibiting fungal cytochrome P-450 dependent enzymes. This enzyme system is essential for the synthesis of ergosterol, a major component of the fungal cell membrane. By inhibiting ergosterol synthesis, fluconazole disrupts the integrity of the fungal cell membrane, leading to the death of the fungus. It is well absorbed after oral administration, and its bioavailability is not significantly affected by food. The plasma half-life is approximately 30 hours, allowing for once-daily dosing in many cases. Most of the drug is excreted unchanged in the urine. 

Dosage and Administration:

Innocan 50 can be taken with or without food. The dosage and duration of treatment vary depending on the type and severity of the fungal infection. It is crucial to complete the full course of treatment as prescribed by the doctor, even if symptoms improve. 

• Vaginal Candidiasis: 150 mg as a single oral dose (a higher strength capsule would be used for this). 
• Oropharyngeal Candidiasis: 200 mg on the first day, then 100 mg once daily for at least 2 weeks. 
• Esophageal Candidiasis: 200 mg on the first day, then 100 mg once daily for 14-30 days. Doses up to 400 mg/day may be used. 
• Systemic Candidiasis and Cryptococcal Infections (including meningitis): 400 mg on the first day, then 200-400 mg daily. Treatment duration depends on clinical response (at least 6-8 weeks for cryptococcal meningitis). 
• Dermal Fungal Infections (Tinea pedis, Tinea cruris, Tinea corporis, Pityriasis versicolor): 150 mg once weekly for 2 to 4 weeks (up to 6 weeks for Tinea pedis), or 50 mg once daily for 2 to 4 weeks. 
• Onychomycosis: 150 mg once weekly, continued until the infected nail is replaced (typically 3-6 months for fingernails, 6-12 months for toenails). 
• Prophylaxis of Fungal Infections in Immunocompromised Patients: 50-400 mg once daily. 
• Children (aged 5-13 years): 3-12 mg/kg daily, maximum 400 mg daily for serious life-threatening infections. Renal clearance in children may be proportionately more rapid than in adults. 

Contraindications:

Innocan 50 is contraindicated in patients with: 

• Known hypersensitivity to Fluconazole, other azole antifungals, or any component of the formulation. 
• Co-administration with terfenadine in patients receiving multiple doses of fluconazole 400 mg/day or more. 
• Co-administration with other drugs known to prolong the QT interval and metabolized via the cytochrome P450 (CYP) 3A4 enzyme (e.g., cisapride, astemizole, pimozide, quinidine, erythromycin). 

Side Effects:

Fluconazole is generally well-tolerated. Common side effects include: 

• Headache 
• Nausea, abdominal pain, diarrhea, vomiting, flatulence 
• Rash 
• Occasionally, abnormalities of liver enzyme tests. 

Less common or serious side effects can include: 

• Abnormal liver function, liver failure. 
• Severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis). 
• Anaphylaxis (severe allergic reaction). 
• QT prolongation and Torsades de Pointes (abnormal heart rhythms), especially in patients with multiple risk factors. 
• Alopecia (hair loss) with long-term therapy. 

Precautions and Warnings:

• Liver Function: Caution is advised in patients with liver disease. Liver function should be monitored, especially in patients who develop abnormal liver function tests during therapy. 
• Renal Impairment: Dose adjustment is required for patients with renal impairment. 
• Cardiac Effects: Use with caution in patients with proarrhythmic conditions, including existing prolongation of the QT interval, hypokalemia, or other electrolyte disturbances, as fluconazole may prolong the QT interval. 
• Driving/Operating Machinery: Patients should be advised about the potential for dizziness or seizures that may impair the ability to drive or operate machinery. 
• Skin Reactions: Patients who develop a rash during treatment should be carefully monitored, and fluconazole should be discontinued if the rash progresses. 
• Immunocompromised Patients: The risk of serious skin reactions is higher in immunocompromised patients. 

Pregnancy and Lactation:

• Pregnancy: Fluconazole is generally avoided during pregnancy unless the potential benefits outweigh the potential risks to the fetus. High doses (400-800 mg/day) used for prolonged periods in the first trimester have been associated with congenital anomalies. For single doses of 150 mg for vaginal candidiasis, the risk appears low. Consult a doctor. 
• Lactation: Fluconazole is found in human breast milk at concentrations similar to plasma. Its use in nursing mothers is generally not recommended due to potential risks to the infant. 

Drug Interactions:

• QT-prolonging drugs and potent CYP3A4 inhibitors: Co-administration is contraindicated (as mentioned above: terfenadine, cisapride, astemizole, pimozide, quinidine, erythromycin). 
• Oral Hypoglycemics (e.g., sulfonylureas like chlorpropamide, glibenclamide, glipizide, tolbutamide): Fluconazole can prolong their serum half-life, increasing the risk of hypoglycemia. Monitor blood glucose closely. 
• Anticoagulants (e.g., Warfarin): Fluconazole can prolong prothrombin time, increasing bleeding risk. Monitor INR. 
• Phenytoin: Fluconazole can increase phenytoin plasma levels, leading to toxicity. 
• Cyclosporine, Tacrolimus, Sirolimus: Fluconazole can increase their plasma levels, increasing the risk of nephrotoxicity. 
• Rifampicin: Rifampicin can decrease fluconazole plasma levels. 
• Theophylline: Fluconazole may decrease the clearance of theophylline. 
• Benzodiazepines (e.g., Midazolam, Triazolam): Fluconazole can increase their plasma levels, leading to prolonged CNS effects. 
• Statins (e.g., Atorvastatin, Simvastatin): Fluconazole can increase their plasma levels, increasing the risk of myopathy and rhabdomyolysis. 

Storage Conditions:

Store in a cool and dry place, protected from light and moisture. Keep out of reach of children. 

Note: This information is for general knowledge and informational purposes only and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication.